1 g
Trade Name
Vanco
Powder for solution for injection or infusion
Request Type
New Registration
Drug Type
Generic(Multisource) Drug
Approval Date
SFDA Approved Use
Intravenous administration
Vancomycin is indicated in all age groups for the treatment of the following infections:
• Complicated skin and soft tissue infections (cSSTI)
• Bone and joint infections
• Community acquired pneumonia (CAP)
• Hospital acquired pneumonia (HAP), including ventilator-associated pneumonia (VAP)
• Infective endocarditis
Vancomycin is also indicated in all age groups for the perioperative antibacterial prophylaxis in patients that are at high risk of developing bacterial endocarditis when undergoing major surgical
procedures.
Oral administration
Vancomycin is indicated in all age groups for the treatment of Clostridium difficile infection (CDI)
Vancomycin is indicated in all age groups for the treatment of the following infections:
• Complicated skin and soft tissue infections (cSSTI)
• Bone and joint infections
• Community acquired pneumonia (CAP)
• Hospital acquired pneumonia (HAP), including ventilator-associated pneumonia (VAP)
• Infective endocarditis
Vancomycin is also indicated in all age groups for the perioperative antibacterial prophylaxis in patients that are at high risk of developing bacterial endocarditis when undergoing major surgical
procedures.
Oral administration
Vancomycin is indicated in all age groups for the treatment of Clostridium difficile infection (CDI)